<div id="readability-page-1"><p>Bank of New York Mellon Corp decreased its position in shares of  Globe Life Inc. (NYSE:GL - Free Report) by 17.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 569,816 shares of the company's stock after selling 118,878 shares during the quarter. Bank of New York Mellon Corp owned about 0.72% of Globe Life worth $79,694,000 as of its most recent SEC filing.</p><ul><li>These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?</li></ul><p>Several other hedge funds and other institutional investors have also bought and sold shares of GL. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in  Globe Life by 6.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company's stock valued at $1,237,000 after buying an additional 607 shares in the last quarter.  NewEdge Advisors LLC lifted its stake in  Globe Life by 368.1% in the first quarter. NewEdge Advisors LLC now owns 6,806 shares of the company's stock valued at $897,000 after buying an additional 5,352 shares in the last quarter.  Goldman Sachs Group Inc. lifted its stake in  Globe Life by 11.5% in the first quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company's stock valued at $74,161,000 after buying an additional 58,163 shares in the last quarter.  Empowered Funds LLC bought a new position in  Globe Life in the first quarter valued at approximately $428,000.  Finally, Focus Partners Wealth lifted its stake in  Globe Life by 8.3% in the first quarter. Focus Partners Wealth now owns 8,559 shares of the company's stock valued at $1,127,000 after buying an additional 656 shares in the last quarter. Institutional investors own  81.61% of the company's stock. </p><h2>Globe Life Price Performance</h2><p>Shares of GL opened at $157.23 on Tuesday. The company has a market cap of $12.21 billion, a price-to-earnings ratio of 10.87 and a beta of 0.49. Globe Life Inc. has a 1-year low of $116.73 and a 1-year high of $159.36. The company's fifty day simple moving average is $150.83 and its 200 day simple moving average is $143.70. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38. </p><ul><li>If the Market Rally Stalls, This ETF Can Insulate Portfolios</li></ul><p>Globe Life (NYSE:GL - Get Free Report) last issued its earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share for the quarter, missing analysts' consensus estimates of $3.46 by ($0.03). Globe Life had a return on equity of 20.94% and a net margin of 19.38%.The firm had revenue of $1.56 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the previous year, the firm posted $3.07 earnings per share. Globe Life's quarterly revenue was up 5.3% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS.  On average, research analysts forecast that  Globe Life Inc. will post 15.62 earnings per share for the current fiscal year. </p><h2>Globe Life Announces Dividend</h2><p>The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be paid a $0.33 dividend. The ex-dividend date is Monday, July 6th. This represents a $1.32 annualized dividend and a dividend yield of 0.8%. Globe Life's dividend payout ratio  is 9.13%. </p><h2>Insider Buying and Selling at Globe Life</h2><ul><li>MarketBeat Week in Review – 05/04 - 05/08</li></ul><p>In related news, CEO Frank M. Svoboda sold 20,000 shares of the company's stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $156.68, for a total value of $3,133,600.00. Following the transaction, the chief executive officer directly owned 54,020 shares in the company, valued at approximately $8,463,853.60. This represents a 27.02% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO James Matthew Darden sold 4,663 shares of the company's stock in a transaction dated Tuesday, April 28th. The shares were sold at an average price of $153.88, for a total transaction of $717,542.44. Following the completion of the transaction, the chief executive officer owned 58,451 shares in the company, valued at $8,994,439.88. This trade represents a 7.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 105,929 shares of company stock valued at $16,382,450. 2.11% of the stock is currently owned by insiders. </p><h2>Wall Street Analyst Weigh In</h2><p>GL has been the topic of a number of research reports. Texas Capital raised shares of Globe Life to a &#34;strong-buy&#34; rating in a research note on Wednesday, March 18th. Morgan Stanley lifted their price target on shares of Globe Life from $176.00 to $181.00 and gave the company an &#34;overweight&#34; rating in a research note on Thursday, May 21st. Piper Sandler lifted their price target on shares of Globe Life from $167.00 to $175.00 and gave the company an &#34;overweight&#34; rating in a research note on Tuesday, May 26th. Truist Financial boosted their price objective on shares of Globe Life from $180.00 to $185.00 and gave the stock a &#34;buy&#34; rating in a research report on Friday, April 24th. Finally, Keefe, Bruyette &amp; Woods  reissued a &#34;moderate buy&#34; rating and issued a $168.00 price objective on shares of Globe Life in a research report on Thursday, March 26th. One equities research analyst  has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have issued  a Hold rating to the stock. According to data from MarketBeat, Globe Life presently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $174.11.</p><p><b>Check Out Our Latest Stock Report on Globe Life</b></p><h2>Globe Life Profile</h2> (Free Report)<p>Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.  </p><p>The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.</p><h2>Recommended Stories</h2><ul><li>Five stocks we like better than Globe Life</li><li>3 Stocks With Fresh Catalysts to Watch Before the July 4</li><li>Amprius Insiders Are Selling: Should Investors Be Worried?</li><li>A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus</li><li>A Market Rotation Toward Quality Will Benefit These 3 ETFs</li></ul><p><strong>Want to see what other hedge funds are holding GL?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GL - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUdM?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUdM"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Globe Life Right Now?</h2><p>Before you consider Globe Life, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.</p><p>While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

GS-D

GS-C

GS-A

<p>Bank of New York Mellon Corp reduced its stake in Globe Life Inc. by 17.3% in Q4, selling 118,878 shares. Meanwhile, other institutions like Goldman Sachs and Mirae Asset increased their holdings. Globe Life recently reported quarterly earnings of $3.43 per share, slightly missing estimates, with revenue up 5.3% year-over-year. The company also declared a $0.33 quarterly dividend. Additionally, CEO Frank Svoboda sold 20,000 shares.</p>

Market Beat

Bank of NY Mellon

Globe Life

GOLDMAN SACHS GROUP INC DEP REP 1/1000TH PRF D

Goldman Sachs

GOLDMAN SACHS GROUP INC DEP SHS REPSTG 1/1000TH PRF SER C

GOLDMAN SACHS GROUP INC DEP SHR REP 1/1000TH PFD SER A

Texas Capital

Morgan Stanley

GLOBE LIFE INC 4.25% JUNIOR SUB DEB DUE 15/06/2061

GS Hldg R

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

Bank of New York Mellon Corp Sells 118,878 Shares of Globe Life Inc. $GL